Análisis de los genes BMPR2, TBX4 y KCNK3 y correlación genotipo-fenotipo en pacientes y familias españolas con hipertensión arterial pulmonar

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Revista Espanola De Cardiologia

• Publication date

  2016-11-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/J.RECESP.2016.03.031
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Defective cellular trafficking of the bone morphogenetic protein receptor type II by mutations underlying familial pulmonary arterial hypertension.

  2015influential reference
• Sex affects bone morphogenetic protein type II receptor signaling in pulmonary artery smooth muscle cells.

  2015cited by this paper
• De Novo Mutations in the BMPR2 Gene in Patients with Heritable Pulmonary Arterial Hypertension

  2015cited by this paper
• A founder EIF2AK4 mutation causes an aggressive form of pulmonary arterial hypertension in Iberian Gypsies

  2015cited by this paper
• Analysis of protein-coding genetic variation in 60,706 humans

  2015cited by this paper
• KCNK3: new gene target for pulmonary hypertension?

  2014cited by this paper
• Novel Mutations in BMPR2, ACVRL1 and KCNA5 Genes and Hemodynamic Parameters in Patients with Pulmonary Arterial Hypertension

  2014cited by this paper
• MutationTaster2: mutation prediction for the deep-sequencing age

  2014cited by this paper
• Mutations of NOTCH3 in childhood pulmonary arterial hypertension

  2014cited by this paper
• Recent Advances in Pulmonary Hypertension

  2014cited by this paper
• A novel channelopathy in pulmonary arterial hypertension.

  2013cited by this paper
• EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension

  2013cited by this paper
• Severely reduced diffusion capacity in idiopathic pulmonary arterial hypertension: patient characteristics and treatment responses

  2013cited by this paper
• Genetics and genomics of pulmonary arterial hypertension.

  2013cited by this paper
• TBX4 mutations (small patella syndrome) are associated with childhood-onset pulmonary arterial hypertension

  2013cited by this paper
• Heritable Forms of Pulmonary Arterial Hypertension

  2013cited by this paper
• Pulmonary arterial hypertension: epidemiology and registries.

  2013cited by this paper
• Diffusion capacity and BMPR2 mutations in pulmonary arterial hypertension

  2013cited by this paper
• Understanding the low penetrance of bone morphogenetic protein receptor 2 gene mutations: another needle in the haystack.

  2012cited by this paper
• Outcomes of childhood pulmonary arterial hypertension in BMPR2 and ALK1 mutation carriers.

  2012cited by this paper
• Survival in pulmonary hypertension in Spain: insights from the Spanish registry

  2012cited by this paper
• Early detection and management of pulmonary arterial hypertension

  2012cited by this paper
• Whole Exome Sequencing to Identify a Novel Gene (Caveolin-1) Associated With Human Pulmonary Arterial Hypertension

  2012cited by this paper
• The REVEAL Registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension.

  2012cited by this paper
• An integrated map of genetic variation from 1,092 human genomes

  2012cited by this paper
• The Minimal Proteome in the Reduced Mitochondrion of the Parasitic Protist Giardia intestinalis

  2011cited by this paper
• Molecular genetics and clinical features of Chinese idiopathic and heritable pulmonary arterial hypertension patients

  2011cited by this paper
• Hemodynamic and clinical onset in patients with hereditary pulmonary arterial hypertension and BMPR2 mutations

  2011cited by this paper
• Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension

  2010cited by this paper
• A method and server for predicting damaging missense mutations

  2010cited by this paper
• Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation.

  2010cited by this paper
• Stress Doppler Echocardiography in Relatives of Patients With Idiopathic and Familial Pulmonary Arterial Hypertension: Results of a Multicenter European Analysis of Pulmonary Artery Pressure Response to Exercise and Hypoxia

  2009cited by this paper
• BODE index versus GOLD classification for explaining anxious and depressive symptoms in patients with COPD – a cross-sectional study

  2009cited by this paper
• Guidelines for the diagnosis and treatment of pulmonary hypertension

  2009cited by this paper
• Truncating and missense BMPR2 mutations differentially affect the severity of heritable pulmonary arterial hypertension

  2009cited by this paper
• Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation.

  2008cited by this paper
• High frequency of BMPR2 exonic deletions/duplications in familial pulmonary arterial hypertension.

  2006cited by this paper
• Genes and Pulmonary Arterial Hypertension

  2006cited by this paper
• Mutations of the TGF‐β type II receptor BMPR2 in pulmonary arterial hypertension

  2006cited by this paper
• High frequency of BMPR 2 exonic deletions / duplications in familial pulmonary arterial hypertension

  2006cited by this paper
• Low frequency of BMPR2 mutations in a German cohort of patients with sporadic idiopathic pulmonary arterial hypertension

  2004cited by this paper
• BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension.

  2001cited by this paper
• Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-β family

  2000cited by this paper
• Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene.

  2000cited by this paper

• The prevalence of pathogenic variants in the BMPR2 gene in patients with the idiopathic pulmonary arterial hypertension in the Russian population: sequencing data and meta-analysis

  2025cites this paper
• The HIF1α-PUM1-KCNK3 axis drives pulmonary hypertension by destabilizing KCNK3 mRNA in pulmonary artery smooth muscle cells.

  2025cites this paper
• The genetic epidemiology and genotype-phenotype correlations among Chinese children with idiopathic and heritable pulmonary arterial hypertension

  2025cites this paper
• X-linked filaminopathy: another pulmonary hypertension syndrome

  2025cites this paper
• RNA‐Seq and ChIP‐Seq Identification of Unique and Overlapping Target Genes and Pathways Regulated by TBX4 in Human Pulmonary Fibroblasts and Pericytes

  2025cites this paper
• Hemodynamic and Genetic Associations with the Risk of Idiopathic Pulmonary Arterial Hypertension Development in an Ethnic Cohort of Kazakhs

  2024influential citation
• Novel Molecular Mechanisms Involved in the Medical Treatment of Pulmonary Arterial Hypertension

  2023cites this paper
• Potassium Channels as Therapeutic Targets in Pulmonary Arterial Hypertension

  2022cites this paper
• Identifying Potential Mutations Responsible for Cases of Pulmonary Arterial Hypertension

  2021cites this paper
• A Genetic Analysis for Patients with Pulmonary Arterial Hypertension

  2020cites this paper
• Genes that drive the pathobiology of pediatric pulmonary arterial hypertension

  2020cites this paper
• Genetics and other omics in pediatric pulmonary arterial hypertension.

  2020cites this paper
• Gender differences in pulmonary arterial hypertension patients with BMPR2 mutation: a meta-analysis

  2020cites this paper
• TBX4 variants and pulmonary diseases: getting out of the ‘Box’

  2020cites this paper
• TBX4 syndrome: a systemic disease highlighted by pulmonary arterial hypertension in its most severe form

  2020cites this paper
• TASK channels: channelopathies, trafficking, and receptor-mediated inhibition

  2020cites this paper
• Phenotype and outcome of pulmonary arterial hypertension patients carrying a TBX4 mutation

  2020cites this paper
• Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH

  2020cites this paper
• The Genetic Epidemiology of Pediatric Pulmonary Arterial Hypertension.

  2020cites this paper
• Customized Massive Parallel Sequencing Panel for Diagnosis of Pulmonary Arterial Hypertension

  2020cites this paper
• Genetics and Genomics of Pediatric Pulmonary Arterial Hypertension

  2020cites this paper
• Phenotype characterisation of TBX4 mutation and deletion carriers with neonatal and paediatric pulmonary hypertension

  2019cites this paper
• Classification of Pulmonary Arterial Hypertension by Genetic and Familial Testing.

  2019cites this paper
• Identification of genetic factors underlying persistent pulmonary hypertension of newborns in a cohort of Chinese neonates

  2019cites this paper
• The ever-expanding phenotypical spectrum of human TBX4 mutations: from toe to lung

  2019cites this paper
• The Biological Bases of Group 2 Pulmonary Hypertension

  2019cites this paper
• Clasificación de la hipertensión arterial pulmonar basada en el estudio genético y familiar

  2019cites this paper
• Characterization and regulation of wild‐type and mutant TASK‐1 two pore domain potassium channels indicated in pulmonary arterial hypertension

  2018influential citation
• Precision medicine and personalising therapy in pulmonary hypertension: seeing the light from the dawn of a new era

  2018cites this paper
• The role of genetics in pulmonary arterial hypertension

  2017cites this paper
• Selección de lo mejor del año 2017 en hipertensión pulmonar

  2017cites this paper
• Idiopathic Pulmonary Arterial Hypertension in Children: A Review

  2017cites this paper
• Molecular Genetic Diagnosis of Pulmonary Arterial Hypertension: An Increased Complexity.

  2016cites this paper
• Diagnóstico genético molecular de la hipertensión arterial pulmonar: una complejidad creciente

  2016cites this paper